ICON Corporate Finance, specialists in M&A for tech companies, has advised EMR (Electronic Medical Record) software company Clinical Computing on its sale to dialysis specific software provider Quantitative Medical Systems.
Headquartered in the UK, with subsidiaries in the US and Australia, Clinical Computing is the developer of a web based EMR solution for the kidney therapeutics market. The company’s solution, captures and manages, at scale, all aspects of a health provider’s clinical, regulatory and operational requirements for effectively managing kidney disease programmes. Clinical Computing’s technology platform serves an estimated 10,000 clinicians across 200 health centres processing millions of clinical records yearly across North America, EMEA and Asia-Pac.
Quantitative Medical Systems offers dialysis specific software solutions to healthcare providers in the US. QMS is part of the Perseus operating group of Constellation Software Inc., an international software company traded publicly on the Toronto Stock Exchange. Constellation Software Inc., acquires, manages, and builds software businesses which provide specialized, mission-critical software solutions.
Sanjay Gandhi, CEO of Clinical Computing, said, “We believe our respective products and markets are complementary and provide our customers and staff with increased choice and opportunity. We are pleased to be part of the QMS Group.”
Paul Benson, General Manager of QMS, said, “This acquisition expands QMS’ presence in the renal software marketplace and will benefit both current and future customers of QMS and Clinical Computing. We look forward to working closely with the team at Clinical Computing.”
Simon Moynagh, Partner at ICON Corporate Finance, who led the deal, commented, “Healthcare is undergoing a radical change with new information technology applications bringing the industry into the 21st century. Clinical Computing operates where the two major growing markets of EMR software and kidney therapeutics overlap, and as such garnered a great deal of international interest and we are delighted to have secured QMS as the acquirer.
“We have worked closely with Clinical Computing for over four years having previously sold their PPM software division, Hydra to Latin American based eTask. We were therefore delighted to have been given the opportunity to advise them on the sale of the core business and are pleased to have secured such a good result.”
“The medical technology provided by Clinical Computing is used by hospitals in Europe, North America and Australia. The sale involved a number of complex international aspects, working with a trusted adviser that skilfully managed these elements of the transaction proved very valuable and led to the deal being completed within a short time frame. It was a pleasure working with the team at ICON.” Sanjay Gandhi, CEO of Clinical Computing.